Back
Sangamo Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20
SGMO
Sangamo Therapeutics
Last Price:
$0.50
Seasonality Move:
9.69%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and SGMO is experiencing buying pressure, which is a positive indicator for future bullish movement.
Sangamo Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.56 | Sell |
20-day SMA: | 0.67 | Sell |
50-day SMA: | 0.74 | Sell |
200-day SMA: | 1.2 | Sell |
8-day EMA: | 0.54 | Sell |
20-day EMA: | 0.62 | Sell |
50-day EMA: | 0.76 | Sell |
200-day EMA: | 1.04 | Sell |
Sangamo Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.08 | Sell |
Relative Strength Index (14 RSI): | 37.76 | Sell |
Chaikin Money Flow: | 2866130 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.57 - 0.79) | Sell |
Bollinger Bands (100): | (0.58 - 1.48) | Sell |
Sangamo Therapeutics Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Sangamo Therapeutics Stock
Is Sangamo Therapeutics Stock a Buy?
-
Sangamo Therapeutics share price is 0.50 while SGMO 8-day simple moving average is 0.56, which is a Sell signal.
-
The stock price of SGMO is 0.50 while Sangamo Therapeutics 20-day SMA is 0.67, which makes it a Sell.
-
Sangamo Therapeutics 50-day simple moving average is 0.74 while SGMO share price is 0.50, making it a Sell technically.
-
SGMO stock price is 0.50 and Sangamo Therapeutics 200-day simple moving average is 1.20, creating a Sell signal.
SGMO Technical Analysis vs Fundamental Analysis
Sell
20
Sangamo Therapeutics (SGMO)
is a Sell
Is Sangamo Therapeutics a Buy or a Sell?
-
Sangamo Therapeutics stock is rated a SellThe current Sangamo Therapeutics [SGMO] share price is $0.50. The Score for SGMO is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Sangamo Therapeutics Stock Info
Market Cap:
122.3M
Price in USD:
0.50
Share Volume:
4.3M
Sangamo Therapeutics 52-Week Range
52-Week High:
3.18
52-Week Low:
0.30
Sell
20
Sangamo Therapeutics (SGMO)
is a Sell
Sangamo Therapeutics Share Price Forecast
-
What is the Sangamo Therapeutics stock price today?The Sangamo Therapeutics stock price is 0.50 USD today.
-
Will SGMO stock go up or go down?Sangamo Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Sangamo Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sangamo Therapeutics is overvalued.
Is Sangamo Therapeutics Stock a Buy?
-
Sangamo Therapeutics share price is 0.50 while SGMO 8-day exponential moving average is 0.54, which is a Sell signal.
-
The stock price of SGMO is 0.50 while Sangamo Therapeutics 20-day EMA is 0.62, which makes it a Sell.
-
Sangamo Therapeutics 50-day exponential moving average is 0.76 while SGMO share price is 0.50, making it a Sell technically.
-
SGMO stock price is 0.50 and Sangamo Therapeutics 200-day simple moving average is 1.04, creating a Sell signal.
Fundamental Analysis of Sangamo Therapeutics
Is Sangamo Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and an increase next year of $0.05 per share.
Technical Analysis of Sangamo Therapeutics
Should I short Sangamo Therapeutics stock?
-
SGMO Moving Average Covergence Divergence (MACD) indicator is -0.08, suggesting Sangamo Therapeutics is a Sell
-
Sangamo Therapeutics Relative Strength Index (RSI) is 37.76, which suggest Sangamo Therapeutics is oversold
-
The Bollinger Bands (25) for Sangamo Therapeutics is (0.57 - 0.79), which suggest Sangamo Therapeutics is a Sell
-
The Bollinger Bands (100) for Sangamo Therapeutics is (0.58 - 1.48), which suggest Sangamo Therapeutics is a Sell
* Sangamo Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.